Phathom Pharmaceuticals, Inc. PHAT Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s other income (expense)?
- Phathom Pharmaceuticals, Inc. (PHAT) reported other income (expense) of -$14.89M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s other income (expense) increased by 3.6% year-over-year, from -$15.45M to -$14.89M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s other income (expense) has grown at a 62.4% compound annual growth rate (CAGR), from -$8.8M to -$61.26M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.